我們已在上線!
進一步了解
Nutriband Inc Warrant
NTRBW
NTRBW
已下市
NTRBW已於2026年9月30日下市。
關於: Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
員工: 3
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
100%
負面
0%
價格圖表採用Lightweight Charts™實作